Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2010
Operating activities
Net (loss) income	$ (22,783)	$ (55,475)	$ 3,547
Income (loss) from discontinued operations	11,456	(32,500)	11,177
Loss from continuing operations	(34,239)	(22,975)	(7,630)
Adjustments to reconcile loss from continuing operations to net cash (used in) provided by operating activities and related charges:
Restructuring and related charges	15,853	405	823
Payments and settlements for restructuring charges	(5,896)	(1,610)	(8,812)
Asset impairments and related charges	9,681	959	236
Depreciation	4,602	3,914	3,260
Amortization	5,910	7,343	6,619
Share based compensation	2,896	2,812	1,947
Loss on sale of securities	148		91
Deferred income taxes	62	4,449	3,383
Change in cash surrender value of corporate-owned life insurance policies	(371)	179	(802)
Gain on redemption of investment in The Reserve Fund's Primary Fund		(147)	(2,505)
Gain on redemption of corporate-owned life insurance policies	(46)	(2,065)
Excess tax benefit from exercise of stock options			(9)
Changes in operating assets and liabilities:
Accounts receivable	(621)	10,256	5,925
Inventories	(4,789)	(859)	3,261
Accounts payable	5,994	(20,477)	9,788
Deferred revenue	4,418	2,865	4,796
Accrued liabilities	(24)	(2,499)	(17,255)
Income taxes payable (receivable)	1,464	7,562	(9,021)
Other changes, net	259	974	3,926
Net cash provided by (used in) operating activities from continuing operations	5,301	(8,914)	(1,979)
Net cash (used in) provided by operating activities from discontinued operations	(26,999)	23,697	105,903
Net cash (used in) provided by operating activities	(21,698)	14,783	103,924
Investing activities
Proceeds from the sale of TSG	55,840
Proceeds from sale of marketable securities	9,237	14	61
Proceeds from redemption of/borrowings against corporate-owned life insurance policies	347	15,980	12,500
Capital expenditures	(4,920)	(6,077)	(13,203)
Additional investments in marketable securities	(53)	(13,731)	(45)
Additional investments in corporate-owned life insurance policies	(112)	(1,129)	(1,712)
Proceeds from The Reserve Fund's Primary Fund		147	4,772
Net cash provided by (used in) investing activities from continuing operations	60,339	(4,796)	2,373
Net cash used in investing activities from discontinued operations		(914)	(103)
Net cash provided by (used in) investing activities	60,339	(5,710)	2,270
Financing activities
Purchase of treasury stock	(13,173)
Exercise of employee stock options	210		89
Repurchase of common shares to satisfy employee tax withholding	(1,449)	(238)
Principal payment under long-term obligations	(1,001)	(370)	(216)
Floor plan financing agreement, net			(6,575)
Proceeds from borrowings under credit facility		15,235	5,077
Principal payments under credit facility		(15,235)	(5,077)
Debt financing costs			(1,578)
Excess tax benefit from exercise of stock options			9
Dividends paid			(1,360)
Net cash used in financing activities from continuing operations	(15,413)	(608)	(9,631)
Net cash used in financing activities from discontinued operations		(49)	(67,893)
Net cash used in financing activities	(15,413)	(657)	(77,524)
Effect of exchange rate changes on cash	5	403	414
Cash flows provided by (used in) continuing operations	50,232	(13,915)	(8,823)
Cash flows (used in) provided by discontinued operations	(26,999)	22,734	37,907
Net increase cash and cash equivalents	23,233	8,819	29,084
Cash and cash equivalents at beginning of year	74,354	65,535	36,451
Cash and cash equivalents at end of year	$ 97,587	$ 74,354	$ 65,535